Please select another video.
Melanoma Drug Shows Promise
Researchers say the drug Keytruda has been able to extend the lives of patients with advanced melanoma. Three years after being treated, 40% of patients are still alive, compared to the usual survival rate of 5%. NBC's Erika Edwards reports.
Your Playlist
Expand
Collapse
